1. 2018 Compounding Policy Priorities Plan released in US

   News item 03 February 2018 Pages: 1 - 1

2. TGA seeks comments on use of strong prescription opioids

   News item 03 February 2018 Pages: 2 - 2

3. US FDA committed to timely public warnings of recalls

   Comment 03 February 2018 Pages: 3 - 3

4. Beta-lactam allergy worsens outcomes and increases costs

   Clinical study 03 February 2018 Pages: 4 - 4

5. Eluxadoline-related pancreatitis: no gallbladder increases risk

   Clinical study 03 February 2018 Pages: 5 - 5

6. Increased dementia risk with tamsulosin in elderly with BPH

   Clinical study 03 February 2018 Pages: 6 - 6

7. Liposomal amphotericin B safe to use in children?

   Clinical study 03 February 2018 Pages: 7 - 7

8. Oral glucocorticoids increase risk and costs of AEs

   Clinical study 03 February 2018 Pages: 8 - 8

9. Perceptions of immunomodulator-related infection risk assessed

   Clinical study 03 February 2018 Pages: 9 - 9

10. Roxithromycin potentiates warfarin

    Clinical study 03 February 2018 Pages: 10 - 10

11. Abacavir/dolutegravir/lamivudine

    Case report 03 February 2018 Pages: 11 - 11

12. Abatacept/rituximab

    Case report 03 February 2018 Pages: 12 - 12

13. Acenocoumarol

    Case report 03 February 2018 Pages: 13 - 13

14. Acetazolamide

    Case report 03 February 2018 Pages: 14 - 14

15. Aciclovir

    Case report 03 February 2018 Pages: 15 - 15

16. Acitretin

    Case report 03 February 2018 Pages: 16 - 16

17. Afatinib

    Case report 03 February 2018 Pages: 17 - 17

18. Alemtuzumab

    Case report 03 February 2018 Pages: 18 - 18

19. Alendronic-acid/etidronic-acid

    Case report 03 February 2018 Pages: 19 - 19

20. Allopurinol

    Case report 03 February 2018 Pages: 20 - 20

21. Alprostadil

    Case report 03 February 2018 Pages: 21 - 21

22. Alteplase

    Case report 03 February 2018 Pages: 22 - 22

23. Alteplase/heparin

    Case report 03 February 2018 Pages: 23 - 23

24. Amiodarone

    Case report 03 February 2018 Pages: 24 - 24

25. Amiodarone

    Case report 03 February 2018 Pages: 25 - 25

26. Amitriptyline/brexpiprazole

    Case report 03 February 2018 Pages: 26 - 26

27. Amlodipine/dipotassium clorazepate overdose

    Case report 03 February 2018 Pages: 27 - 27

28. Amoxicillin

    Case report 03 February 2018 Pages: 28 - 28

29. Amoxicillin/clavulanic acid

    Case report 03 February 2018 Pages: 29 - 29

30. Amoxicillin/clavulanic acid/warfarin interaction

    Case report 03 February 2018 Pages: 30 - 30

31. Amoxicillin/clavulanic-acid

    Case report 03 February 2018 Pages: 31 - 31

32. Amphotericin-B

    Case report 03 February 2018 Pages: 32 - 32

33. Anticoagulants/antiplatelets

    Case report 03 February 2018 Pages: 33 - 33

34. Antineoplastics

    Case report 03 February 2018 Pages: 34 - 34

35. Antineoplastics

    Case report 03 February 2018 Pages: 35 - 35

36. Antineoplastics

    Case report 03 February 2018 Pages: 36 - 36

37. Antineoplastics

    Case report 03 February 2018 Pages: 37 - 37

38. Antineoplastics

    Case report 03 February 2018 Pages: 38 - 38

39. Antipsychotics

    Case report 03 February 2018 Pages: 39 - 39

40. Antiretrovirals

    Case report 03 February 2018 Pages: 40 - 40

41. Artesunate

    Case report 03 February 2018 Pages: 41 - 41

42. Aspirin/warfarin

    Case report 03 February 2018 Pages: 42 - 42

43. Aspirin/warfarin

    Case report 03 February 2018 Pages: 43 - 43

44. Asunaprevir/daclatasvir

    Case report 03 February 2018 Pages: 44 - 44

45. Atorvastatin/rosuvastatin

    Case report 03 February 2018 Pages: 45 - 45

46. Autologous formalin fixed tumour cell vaccine

    Case report 03 February 2018 Pages: 46 - 46

47. Azathioprine/prednisone/tacrolimus

    Case report 03 February 2018 Pages: 47 - 47

48. Azithromycin/ceftriaxone/cotrimoxazole

    Case report 03 February 2018 Pages: 48 - 48

49. Baclofen

    Case report 03 February 2018 Pages: 49 - 49

50. Bevacizumab and ipilimumab/nivolumab

    Case report 03 February 2018 Pages: 50 - 50